WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: APRIL ISSUE PUBLISHED

    APRIL 2026 Issue has been successfully launched on APRIL 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR April 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

SUPERIOR ANALGESIC EFFICACY OF LOW-DOSE INTRAVENOUS TRAMADOL-PARACETAMOL COMBINATION VERSUS HIGHER-DOSE TRAMADOL MONOTHERAPY IN POSTOPERATIVE PAIN MANAGEMENT AFTER ELECTIVE ABDOMINAL SURGERY

Ahmed A. Eeda*, Mohanad Abdul Kareem Hilal, Haydar Samir Abdullatif

ABSTRACT

Background: Postoperative pain management remains inadequate for many patients despite advances in analgesics, as it can lead to complications like respiratory issues, cardiovascular strain, thromboembolism, and stress responses. Opioids such as tramadol provide potent relief but cause side effects including nausea, vomiting, and respiratory depression, prompting research into combinations with paracetamol for better efficacy and safety. Patients and Methods: This cross-sectional study at Al-Hussein Teaching Hospital (January-December 2025) enrolled 150 adults (18-65 years, ASA I-II) undergoing elective abdominal surgery under general anesthesia, randomized into two groups of 75: Group I received 1 mg/kg IV tramadol + 1 g paracetamol; Group II received 1.5 mg/kg IV tramadol. Pain was assessed via VAS at 2, 6, 12, and 24 hours postoperatively; data analyzed with SPSS v26 (p≤0.05 significant). Results: Baseline demographics (age, gender, BMI, ASA, surgery type/duration) were comparable between groups (p>0.05). The combination group showed significantly lower VAS scores: 5.3±0.8 vs. 6.12±0.7 (2h, p=0.001), 5.2±1.4 vs. 5.8±1.0 (6h, p=0.001), 2.3±0.9 vs. 2.8±1.0 (12h, p=0.022), 1.2±0.8 vs. 2.1±0.8 (24h, p=0.003). Conclusion: Low-dose tramadol-paracetamol combination provides superior postoperative analgesia compared to higher-dose tramadol alone, with lower pain scores across all time points, aligning with prior studies showing reduced complications like nausea.

[Full Text Article] [Download Certificate]